Home
Avidity Biosciences

Avidity Biosciences Market Share Analysis for March 2026

Health > Biotechnology and Pharmaceuticals

Domainaviditybiosciences.com

Year Founded2012

Employees51 - 200

Annual Revenue$15M - $25M

Avidity Biosciences

Avidity Biosciences (including company regionals)

aviditybiosciences.com

See more website traffic and engagement information

Avidity Biosciences Revenue up to March 2026 is 15M - 25M

revenue generated by Avidity Biosciences top domains

Avidity Biosciences top domains revenue over 3 years

Revenue for Avidity Biosciences top domains

aviditybiosciences.com15M - 25M

See more with Sales Intelligence

Total visits to Avidity Biosciences's top domains

Understand Avidity Biosciences market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

aviditybiosciences.com16.6K

See more with Sales Intelligence

Avg. visit duration in Avidity Biosciences's top domains

Analyze Avidity Biosciences engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

aviditybiosciences.com00:00:23

See more with Sales Intelligence

Avg. pageviews on Avidity Biosciences's top domains

See how Avidity Biosciences keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

aviditybiosciences.com1.68

See more with Sales Intelligence

Avidity Biosciences top competitors by domain

Top similar sites in March 2026, ranked by their affinity

arcturusrx.comCompany NameArcturus Therapeutics Holdings Inc.Employees51 - 200HQUnited States, California, San DiegoAnnual revenue$100M - $200MTotal visits19KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Avidity Biosciences

These are the website technologies, by industry, used by Avidity Biosciences top domains

Widget (8)

Twemoji

Conversion & Analytics (3)

Google Analytics

Audio Video Media (2)

YouTube

Content Management System (2)

WordPress

More Technologies

6

See all

News & Signals from Avidity Biosciences

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsChristy Shafer left Avidity Biosciences, Inc. as Senior Vice President and General Manager, North America on Apr 1st '26.Christy Shafer most recently served as Senior Vice President and General Manager, North America, of Avidity Biosciences, a late-stage biotech developing RNA therapeutics for rare neuromuscular diseases that was acquired by Novartis.

NewsAvidity Biosciences, Inc. attends event 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference.Avidity Biosciences announces multiple upcoming presentations at 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference.

NewsAvidity Biosciences, Inc. launches U.S. access program for del-zota in DMD exon 44 patients.Avidity Biosciences launches U.S. access program for del-zota in DMD exon 44 patients.